ADC Therapeutics SA (ADCT) stock
ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.35+0.10 (+8.00%)
Close on Nov 17, 2026Market cap $172.35MP/E –Yield –
ADC Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
ADC Therapeutics's price to sales ratio was 2.6× on Nov 11, 2026, against 6.4× a year earlier. Over the last 5 years it ranged from 0.3× to 91.7×, with a median of 3.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.6× | −2.7 |
| 2025 | Dec 31, 2025 | 5.3× | +2.6 |
| 2024 | Dec 31, 2024 | 2.7× | +1.6 |
| 2023 | Dec 29, 2023 | 1.1× | −0.8 |
| 2022 | Dec 30, 2022 | 1.9× | −89.8 |
| 2021 | Dec 31, 2021 | 91.7× | – |
See a number that looks wrong?